CONTROLLED DOUBLE BLIND STUDY TO EVALUATE THE SAFETY, REACTOGENICITY, AND IMMUNOGENICITY OF THE CANDIDATE PLASMODIUM FALCIPARUM MALARIA PROTEIN 010 (FMP010) ADMINISTERED INTRAMUSCULARLY WITH GSK BIOLOGICALS' ADJUVANT AS01B: